• STAT+: ‘There are no alternatives': As Pfizer discontinues an old glaucoma drug, a small group of patients struggles to cope

    15 days ago - By STAT

    Next month, an eye drop that Carol Vaghar has taken for the past few years to manage a rare form of glaucoma will no longer be available, leaving her little choice but to consider potentially risky surgery to maintain the pressure in her eyes.
    The 62-year-old real estate agent developed cataracts in both eyes many years ago and after surgery, developed aphakic glaucoma, which causes intraocular pressure to rise dramatically. Vaghar tried various medications, but only one - a decades-old eye drop called Phospholine Iodide - has been effective. But Pfizer , which is the only supplier, will...
    Read more ...